2026-07-06
No AI summary for this filing type
View Full Filing (SEC EDGAR)Nuvation Bio INC
-$974.4M
Net Activity
Institutions Holding
232
Popularity Rank
#2547
Avg Weight
0.25%
Total Value
$949.2M
232 institutions currently hold NUVB, with 129 net buyers and 99 net sellers this quarter.
Institutional Moves (Q1 2026)
Neutral
Based on recent trading activity
Net Selling Institutions
99
Net Buying Institutions
129
Top 5 by Value
+$578.9M
Total Buy Value
$495.7M
Total Sell Value
129
Net Buyers
99
Net Sellers
3
Filings (90d)
$1.36M
Total Est. Value
236K shares
Planned Shares
| Filer | Filing Date | Est. Value |
|---|---|---|
| Markel Stacy | 2026-06-23 | $720K |
| Wentworth Kerry | 2026-06-23 | $363K |
| Makunje Moses | 2026-06-23 | $275K |
Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker。
No Schedule 13D/13G filings for this ticker
2
Filings (14d)
No AI summary for this filing type
View Full Filing (SEC EDGAR)Nuvation Bio completed a $250 million offering of 0.75% convertible senior notes due in 2032. The notes are convertible into Class A common stock at an initial conversion price of approximately $7.84 per share, a 35% premium from the recent stock price. The company also amended its Revenue Interest Financing Agreement to permit this issuance.
View Full Filing (SEC EDGAR)The most-added stocks by 13F institutions this quarter
Institutions Holding
6,150
Total reported value
$2.1T
3245 13F institutions increased their position this quarter
Institutions Holding
5,957
Total reported value
$1.5T
3028 13F institutions increased their position this quarter
Institutions Holding
5,764
Total reported value
$3.0T
2743 13F institutions increased their position this quarter